Challenges in Pharmacological Management of Cardiovascular Diseases in Covid-19: do Benefits Outweigh Risks?
Samuel de Sousa Pedro, Fernanda Brito, Christianne Brêtas Vieira Scaramello
Abstract
Introduction Cardiovascular diseases (CVD) are the main cause not only of global mortality but also of reduced quality of life. They cover ischemic heart disease, stroke, heart failure, peripheral artery disease, and various other heart and vascular conditions. In 2017, CVDs caused about 17.8 million deaths worldwide, corresponding to 330 million years of life lost and another 35.6 million years of life with disabilities. Almost 80% of deaths occur in low- and middle-income countries, such as Brazil, where the occurrence [...]
Topics & Concepts
MedicineStroke (engine)Heart failureDiseaseCoronavirus disease 2019 (COVID-19)Quality of life (healthcare)Intensive care medicineInternal medicineInfectious disease (medical specialty)EngineeringNursingMechanical engineeringCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Blood Pressure and Hypertension Studies